Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2022-07-05 00:00:00 ET · period of report 2022-06-30 · accession 0001437749-22-016566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-05 | 2022-06-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $1.50 | +2,500 | 65.5K | +4% | +$3,750 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-30 | A | A | 2,500 | $1.50 | 65,500 | D | — | — | (F2) Holdings do not include options to purchase 20,834 shares. |